Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Theralink Technologies

THEROTCEM

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$0.00010

At close: Mar 1, 9:17 AM EDT

$0.00110

0.001001000.00%

After Hours: Mar 1, 9:17 AM EDT

Theralink Technologies (THER) Forecast

News

Earnings Theralink Technologies (THER) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Theralink Technologies (OTC:THER) Stock

Theralink Technologies Stock (OTC: THER)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, November 13, 2023

Theralink And IMAC Holdings Announce Receipt ...
Benzinga Newsdesk

Tuesday, May 23, 2023

Theralink Signs Definitive Merger Agreement T...
Benzinga Newsdesk

Monday, January 21, 2013

Theratechnologies Announces FDA Approves SNDA for Alternative Storage Conditions for EGRIFTA
Benzinga

Thursday, September 27, 2012

Stocks Hitting 52-Week Lows
Benzinga

Monday, June 25, 2012

Winning Trades Based on Analyst Ratings for June 25
Benzinga
UPDATE: Bloom Burton Downgrades Theratechnologies to Sell, Lowers PT
Benzinga
Bloom Burton & Co. Downgrades Theratechnologi...
Benzinga

Friday, June 22, 2012

Theratechnologies Down 57% on Tesamorelin Non-Compliance Notice
Benzinga
Mid-Day Market Losers
Benzinga

Tuesday, February 21, 2012

Theratechnologies Announces a Supply, Distribution and Licensing Agreement With Actelion Pharmaceuticals Canada
Benzinga

Wednesday, December 07, 2011

PREVIEW:Theratechnolgies to Resume Trading at...
Benzinga
Theratechnolgies Halted; Pending News
Benzinga

Wednesday, October 19, 2011

Theratechnologies Announces Application for Registration of Tesamorelin in Mexico
Benzinga

Tuesday, September 06, 2011

Theratechnologies Launches Phase 2 Clinical Trial to Investigate Tesamorelin for the Treatment of COPD-Associated Muscle Wasting
Benzinga

Tuesday, July 19, 2011

Theratechnologies: Results of Independent Study on the Effect of Tesamorelin on Cognitive Function Presented at Conference in France
Benzinga

Thursday, July 07, 2011

Theratechnologies Expects 2011 US EGRIFTA Sal...
Benzinga

Tuesday, July 05, 2011

Theratechnologies Announces the Filing of an Application for Registration of Tesamorelin in Israel by Sanofi
Benzinga

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved